Endothelin Receptor Antagonists in Heart Failure: Current Status and Future Directions

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.10, 2004-01, pp. : 1029-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heart failure and endothelin receptor antagonists

By Miyauchi T. Goto K.

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 210-217

Elsevier

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists: Current Concepts and Future Directions

By Ferguson J.J. Zaqqa M.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Chronic Heart Failure: Current Evidence, Challenges to Therapy, and Future Directions

By Morrissey Ryan P. Czer Lawrence Shah Prediman K.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 3, 2011-06 ,pp. : 153-171

Adis International

Access to resources Recommend Favorite

Vasopressin receptor antagonists in heart failure

By Thibonnier M.

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 683-687

Elsevier

Access to resources Recommend Favorite

An update on the status of endothelin receptor antagonists for hypertension

By Dao Huy Hao Moreau Pierre

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1937-1946

Informa Healthcare

Access to resources Recommend Favorite